E-NEWS FROM THE NATIONAL VACCINE INFORMATION CENTER
Vienna, Virginia
http://www.909shot.com* * * * * * * * * * * * * * * * * * * * * * *
UNITED WAY/COMBINED FEDERAL CAMPAIGN
#9119
* * * * * * * * * * * * * * * * * * * * * * *
"Protecting the health and informed consent rights of children since 1982."
==========================================================================================
NVIC Note:
This is the kind of investigation into children at high risk for vaccine reactions that should be funded and conducted in the U.S. by government and industry instead of promoting "one-size-fits-all" vaccine policies that write vulnerable children off as expendable.
The lack of scientific research into vaccine side effects and high risk factors will be highlighted at the Third International Public Conference on Vaccination sponsored by the National Vaccine Information Center next week Nov. 7-9, 2002 in Arlington, VA (next to Regan National Airport). More than 30 researchers, clinicians, bioethicists, legal experts and vaccine safety advocates will tell what they know. There is still time to register and get low hotel rates ($109 per night). Go to
www.909shot.com or call 770-977-7991. http://www.docguide.com/news/content.nsf/news/8525697700573E1885256C4E001C7B2A?OpenDocument&id=03E05ADF052F2F3E852568C000807CA5&c=Vaccinology&count=10
Some Children With Allergies At High Risk Of Measles Vaccine Side Effects A DGReview of :"Measles vaccination for children with allergic diseases" Japanese Journal of Allergy (Arerugi)
10/24/2002
By Elda Hauschildt
Some children with allergies should be considered high risk for side effects of measles vaccine.
Children undergoing food elimination therapy (besides egg) and those with specific immunoglobin E (IgE) greater than 3.5 UA/mL for egg white or greater than 0.35 UA/mL for cat dander should be included in this high-risk category, Japanese researchers say.
They suggest use of an intradermal skin test with 1:100 dilution to ascertain whether allergic children will react.
Seventy five children with allergies were tested using three types of skin
tests: prick tests with undiluted vaccine, prick tests with 1:10 dilution and/or intradermal test with 1:100 dilution.
Children who tested negative on the skin tests received subcutaneous 0.5 mL doses of vaccine. Those who tested positive or positive/negative on at least one skin test were given subcutaneous vaccine in a divided method, using increments of 0.05 mL.
Investigators from Kanagawa Children's Medical Centre report the intradermal test with 1:100 dilution showed the highest sensitivity (88
percent) and relatively high specificity (75 percent) in predicting side effects.
A total of 49 children received normal vaccinations; 26 were treated using the divided method.
Children given vaccine by the divided method were more likely to be using elimination therapy for foods besides egg and to have significantly higher total IgE and specific IgE for egg white, cow's milk, wheat and cat dander.
Twenty five of the 26 children had specific IgE for egg white greater than 3.5 UA/mL; 8 of 11 showed specific IgE for cat dander greater than 0.35 UA/mL.
Side effects appeared in eight of the children. In seven, skin reaction was the only side effect. There were no cases of anaphylaxis. Japanese Journal of Allergy (Arerugi), 2002; 51: 622-629. "Measles vaccination for children with allergic diseases"
=============================================
News@909shot.com is a free service of the National Vaccine Information Center and is supported through membership donations. Learn more about vaccines, diseases and how to protect your informed
consent rights
http://www.909shot.comBecome a member and support NVIC's work
https://www.909shot.com/order.htmTo sign up for a free e-mail subscription
http://www.909shot.com/emaillist.htmTo unsubscribe from this list, send an email to news-request@909shot.com and type
UNSUBSCRIBE in the body of the email.
NVIC is funded through individual membership donations and does not receive government funding. Barbara Loe Fisher, President and Co-founder.
NOTE: This is not an interactive e-mail list. Please do not respond to messages.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.